194 related articles for article (PubMed ID: 7042197)
1. Hemoperfusion in 1981.
Chang TM
Contrib Nephrol; 1982; 29():11-22. PubMed ID: 7042197
[TBL] [Abstract][Full Text] [Related]
2. A 1978 perspective of hemoperfusion.
Chang TM
Artif Organs; 1978 Nov; 2(4):359-62. PubMed ID: 743005
[TBL] [Abstract][Full Text] [Related]
3. Microencapsulated adsorbent hemoperfusion for uremia, intoxication and hepatic failure.
Chang TM
Kidney Int Suppl; 1975 Feb; (3):387-92. PubMed ID: 1099317
[No Abstract] [Full Text] [Related]
4. Artificial cells in hemoperfusion and other applications.
Chang TM
Nephron; 1984; 36(3):161-8. PubMed ID: 6366599
[TBL] [Abstract][Full Text] [Related]
5. Coated charcoal haemoperfusion.
Chang TM
Life Support Syst; 1984; 2(2):99-106. PubMed ID: 6384672
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of chronic uremia with albumin/collodion-coated activated charcoal--A preliminary report].
Amdahl T; Peterson JO
Lakartidningen; 1975 Feb; 72(7):587-8. PubMed ID: 1113574
[No Abstract] [Full Text] [Related]
7. Hemoperfusion based on artificial cells for aluminium and iron removal, immunosorption, fulminant hepatic failure, uremia, poisoning and metabolic assists.
Chang TM
Int J Artif Organs; 1986 Sep; 9(5):285-8. PubMed ID: 3781657
[TBL] [Abstract][Full Text] [Related]
8. Hemoperfusion for uremia: past, present, and future.
Winchester JF; Ash SR
Kidney Int Suppl; 1985 Dec; 17():S127-30. PubMed ID: 3867782
[No Abstract] [Full Text] [Related]
9. Hemoperfusion in toxic ingestions and hepatic encephalopathy: have the expectations been achieved?
Gelfand MC
Contrib Nephrol; 1982; 29():101-13. PubMed ID: 7075211
[No Abstract] [Full Text] [Related]
10. Realities in evaluating the clinical uses of sorbent hemoperfusion.
Winchester JF; Gelfand MC; Knepshield JH; Schreiner GE
Int J Artif Organs; 1979 Nov; 2(6):310-4. PubMed ID: 511372
[No Abstract] [Full Text] [Related]
11. Present and future uses of hemoperfusion with sorbents.
Winchester JF; Gelfand MC; Knepshield JH; Schreiner GE
Artif Organs; 1978 Nov; 2(4):353-8. PubMed ID: 743004
[No Abstract] [Full Text] [Related]
12. Hemoperfusion alone and in series with ultrafiltration or dialysis for uremia, poisoning and liver failure.
Chang TM
Kidney Int Suppl; 1976 Dec; (7):S305-11. PubMed ID: 1070552
[No Abstract] [Full Text] [Related]
13. Blood purification by haemoperfusion.
Klinkmann H; Falkenhagen D; Courtney JM
Int J Artif Organs; 1979 Nov; 2(6):296-308. PubMed ID: 511371
[TBL] [Abstract][Full Text] [Related]
14. In vitro assessment of charcoal and resin hemoadsorbents.
Falkenhagen D; Gottschall S; Esther G; Courtney JM; Klinkmann H
Contrib Nephrol; 1982; 29():23-33. PubMed ID: 7075214
[TBL] [Abstract][Full Text] [Related]
15. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
Chirito E; Reiter B; Lister C; Chang TM
Artif Organs; 1977 Aug; 1(1):76-83. PubMed ID: 616275
[TBL] [Abstract][Full Text] [Related]
16. Hemoperfusion: present and future.
Gelfand MC
J Dial; 1979; 3(1):1-9. PubMed ID: 469100
[No Abstract] [Full Text] [Related]
17. [Treatment of comatose patients by extracorporeal hemoperfusion with activated charcoal].
Lie TS; Kim WI; Rommelsheim K; Holst A
MMW Munch Med Wochenschr; 1976 Jul; 118(29-30):945-8. PubMed ID: 820984
[TBL] [Abstract][Full Text] [Related]
18. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
[No Abstract] [Full Text] [Related]
19. Hemoperfusion in chronic uremia.
Stefoni S; Feliciangeli G; Cianciolo G; De Sanctis LB; Giardino R; Spighi M
Boll Soc Ital Biol Sper; 1993 Nov; 69(11):675-82. PubMed ID: 8060597
[TBL] [Abstract][Full Text] [Related]
20. Reflections on the role of carbon haemoadsorption in therapeutic medicine.
Gilchrist T
Contrib Nephrol; 1982; 29():34-52. PubMed ID: 7042198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
